For many men, especially after prostate-cancer surgery, urinary incontinence is a quietly life-altering problem. A new device aims to address it with a modern twist: a remote-controlled artificial urinary sphincter that a man can operate with the press of a button the size of a car-key fob.

The problem

Stress urinary incontinence — leaking urine with coughing, lifting or movement — is common after treatment for prostate and other pelvic cancers, which can damage the muscles and nerves that keep the bladder closed. For men whose incontinence is severe, the standard surgical fix is an artificial urinary sphincter (AUS): an implanted cuff that squeezes the urethra shut, which the patient manually releases to urinate.

The limitation of current devices

Traditional artificial sphincters are mechanical and manual: to urinate, the man has to reach down and squeeze a pump implanted in the scrotum to deflate the cuff. That can be genuinely difficult for older men with limited hand strength or dexterity — arthritis, for instance — and many find the reach-and-pump motion awkward or embarrassing to do discreetly in a public restroom.

How the new device works

The new system, called UroActive, is an electronic artificial sphincter. A control unit — roughly like a pacemaker — is implanted under the skin of the abdomen, connected to a pump, a fluid reservoir, a urethral cuff and a battery. Instead of a manual squeeze, the patient presses a wireless remote control to deflate the cuff when he needs to urinate. The aim is a more discreet and physically easier experience, removing the grip-strength barrier.

The early evidence

A first-in-human study, published in the Journal of Urology, followed 6 men with stress urinary incontinence over 365 days and found the device functional with acceptable safety. Separately, a surgical team at Duke Health recently performed the first implantations in the United States, targeting men left incontinent after cancer treatment. It’s a promising start for a long-standing unmet need.

Why it matters — and the caveats

Incontinence carries a heavy toll on dignity, mental health and social life, and men often suffer in silence. A device that’s easier to operate could expand who can benefit and improve quality of life. But the caution is important: this is a very small, early study — just six men — designed to show the device works and is reasonably safe, not to prove long-term durability or superiority over existing sphincters. Electronic implants also raise questions about battery life, reliability and repairs over years of use. Larger, longer studies will determine whether the remote-controlled approach becomes a mainstream option. This summarizes early research and is not medical advice.